Page 3 - Congenital Anomalies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Congenital anomalies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Congenital Anomalies Today - Breaking & Trending Today

ProKidney Corp. (NASDAQ:PROK) Major Shareholder Sells $9,299,000.00 in Stock

ProKidney Corp. (NASDAQ:PROK – Get Free Report) major shareholder Chamath Palihapitiya sold 1,700,000 shares of the business’s stock in a transaction that occurred on Tuesday, September 19th. The stock was sold at an average price of $5.47, for a total value of $9,299,000.00. Following the transaction, the insider now directly owns 2,073,000 shares in the […] ....

United States , Chamath Palihapitiya , Prokidney Corp , Wells Fargo Company , Goldman Sachs Group Inc , Nuveen Asset Management , Prokidney Company Profile , Lazard Asset Management , Get Free Report , Kidney Stock Down , State Teachers Retirement System , Asset Management , Sachs Group , Kidney Corp , Renal Autologous Cell Therapy , Congenital Anomalies , Urinary Tract , Prokidney Daily , Nasdaq Prok , Insider Trading , Nsider Trades ,

Insider Selling: ProKidney Corp. (NASDAQ:PROK) Major Shareholder Sells 1,700,000 Shares of Stock

ProKidney Corp. (NASDAQ:PROK – Get Free Report) major shareholder Chamath Palihapitiya sold 1,700,000 shares of the company’s stock in a transaction that occurred on Tuesday, September 19th. The stock was sold at an average price of $5.47, for a total value of $9,299,000.00. Following the transaction, the insider now directly owns 2,073,000 shares in the […] ....

Chamath Palihapitiya , Securities Exchange Commission , Salem Investment Counselors Inc , Life Insurance Co , Lazard Asset Management , Prokidney Company Profile , Prokidney Corp , Tower Research Capital , Ameritas Investment Partners Inc , Get Free Report , Exchange Commission , Asset Management , Investment Counselors , Research Capital , Ameritas Investment Partners , Kidney Corp , Renal Autologous Cell Therapy , Congenital Anomalies , Urinary Tract , Prokidney Daily , Nasdaq Prok , Insider Trading , Nsider Trades ,

ProKidney (NASDAQ:PROK) Stock Price Down 5.7%

ProKidney Corp. (NASDAQ:PROK – Get Free Report) shares were down 5.7% on Tuesday . The company traded as low as $7.81 and last traded at $7.87. Approximately 69,493 shares changed hands during mid-day trading, a decline of 73% from the average daily volume of 252,825 shares. The stock had previously closed at $8.35. Analysts Set […] ....

Blackrock Inc , Prokidney Company Profile , Morgan Stanley , Geode Capital Management , Prokidney Corp , Capital Group , Get Free Report , Street Corp , Capital Management , Kidney Corp , Renal Autologous Cell Therapy , Congenital Anomalies , Urinary Tract , Prokidney Daily , Nasdaq Prok ,

Comparing Coeptis Therapeutics (NASDAQ:COEP) & ProKidney (NASDAQ:PROK)

ProKidney (NASDAQ:PROK – Get Free Report) and Coeptis Therapeutics (NASDAQ:COEP – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, profitability, earnings, analyst recommendations, institutional ownership, dividends and valuation. Analyst Recommendations This is a summary of current […] ....

North Carolina , United States , Winston Salem , Statera Biopharma , Prokidney Corp , Coeptis Therapeutics Holdings Inc , Vici Health Sciences , Get Free Report , Coeptis Therapeutics , Given Coeptis Therapeutic , Coeptis Therapeutic , Kidney Corp , Renal Autologous Cell Therapy , Congenital Anomalies , Urinary Tract , Therapeutics Holdings , Coeptis Therapeutics Holdings , Prokidney Daily , Nasdaq Prok , Stock Comparison , Stock Analysis ,